+948.4%
MRNA vs FHN
+90.7%
+857.7%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | FHN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -2.1% | -0.1% | -2.1% |
| 7D | -12.7% | -7.5% | -5.2% | -12.6% |
| 30D | -20.7% | -6.2% | -14.5% | -20.6% |
| 3M | +46.3% | -11.2% | +57.5% | +46.5% |
| 6M | +305.2% | -9.0% | +314.2% | +304.2% |
| YTD | +561.2% | -7.0% | +568.2% | +558.8% |
| 1Y | +772.1% | +5.0% | +767.1% | +764.0% |
| 3Y | +147.0% | +95.1% | +51.9% | +143.0% |
| 5Y | -26.1% | +53.6% | -79.7% | -26.9% |
| All | +948.4% | +90.7% | +857.7% | +1,085.7% |
Cumulative growth
Daily Returns
Daily percentage return beside FHN.
Daily Out/Under-Performance
Portfolio return minus FHN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FHN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded FHN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling